ENDPOINTS

#ASCO25: Researchers debate how best to use checkpoint drugs in earlier cancers

CHICAGO — Checkpoint therapies, which made their name as treatments for patients with metastatic cancer, are now being implemented in a wide range of less-advanced cancers alongside surgery. The goal is not just to extend a ...

Jun 1, 2025 - 13:04
 0
#ASCO25: Researchers debate how best to use checkpoint drugs in earlier cancers
CHICAGO — Checkpoint therapies, which made their name as treatments for patients with metastatic cancer, are now being implemented in a wide range of less-advanced cancers alongside surgery. The goal is not just to extend a ...
Read More

Tags:

Previous Article

#ASCO25: AstraZeneca details Phase 3 data for oral SERD 'switching' regimen

Next Article

#ASCO25: Takeda, Protagonist unveil data for rare blood disease drug

Related Posts

Endpoints Livestream: Trump's 'Most Favored Nation' plan to cut drug prices

Endpoints Livestream: Trump's 'Most Favored Nation' pla...

May 13, 2025  0

Pathos AI collects $365M to fuel data-driven oncology studies

Pathos AI collects $365M to fuel data-driven oncology s...

May 15, 2025  0

Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise

Pharma investors brush off Trump’s ‘most favored nation...

May 12, 2025  0